Physician profile
Shirin Barez
NPI 1659338952
$1,643.41
in general payments reported to CMS, 2019-2025
20 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $100 · 2021: $155 · 2022: $208 · 2023: $182 · 2024: $662 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004 · Entertainment: $16.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.50 |
| Entertainment | $16.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $255.04 | 2023-2025 | Syfovre |
| Genentech USA, INC. | $251.80 | 2022-2025 | Vabysmo |
| Biotissue Holdings INC. | $203.08 | 2024 | |
| Novartis Pharmaceuticals Corporation | $169.03 | 2019-2021 | |
| Allergan, INC. | $136.69 | 2019-2022 | |
| Eyepoint US, INC. | $104.02 | 2024 | |
| Johnson & Johnson Surgical Vision, INC. | $97.99 | 2021-2022 | |
| Alcon Vision LLC | $91.79 | 2022-2025 | Eysuvis, Rocklatan |
| Bausch & Lomb Americas INC. | $63.56 | 2022-2024 | Alrex, Zylet, Prolensa |
| Merz Pharmaceuticals, LLC | $34.21 | 2023 | Xeomin |
| Harrow Eye, LLC | $33.84 | 2025 | Vevye |
| Astellas Pharma US INC | $30.31 | 2024 | Izervay |
| Sun Pharmaceutical Industries INC. | $26.32 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.87 | 2019 | |
| Coopervision INC. | $24.80 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $23.82 | 2024 | Rxsight Injector Cartridge, Rxsight Injector Handpiece, Rxsight Contact Lens |
| Regeneron Healthcare Solutions, INC. | $21.39 | 2021 | |
| Aerie Pharmaceuticals, INC. | $20.62 | 2021 | |
| Optos, INC. | $16.14 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Kala Pharmaceuticals, INC. | $14.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirin Barez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.